Check out our interview with Kenneth Barr, SVP, Discovery Services, Syngene as he talks about targeted protein degradation emerging as a transformative new therapeutic modality.
Sygnene is accelerating therapeutic discovery and we’re thrilled they are a part of our Science Exchange Contracted™ network of 3,300+ CROs, CMOs, and academic labs offering their services to help research organizations accelerate drug discoveries and innovation. […]
Expand your access to innovative toxicology services through the Science Exchange Network, as we are continuously adding new services and qualified providers. Here are four recent additions that could inspire your next breakthrough. Visit each provider’s online profile to learn more about the technologies listed. […]
Expand your access to innovation through the Science Exchange Network, as we are continuously adding new services and qualified providers. Here are five recent additions that could inspire your next breakthrough. Visit each provider’s online profile to learn more about the technologies listed. […]
Expand your access to innovation through the Science Exchange Network, as we are continuously adding new services and qualified providers. Here are five recent additions that could inspire your next breakthrough. Visit each provider’s online profile to learn more about the technologies listed. […]